相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials
Farhad Faridhosseini et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Diabetes Mellitus and Disturbances in Brain Connectivity: A Bidirectional Relationship?
Rodrigo B. Mansur et al.
NEUROMOLECULAR MEDICINE (2014)
Rheumatoid Arthritis and the Risk of Bipolar Disorder: A Nationwide Population-Based Study
Chih-Chao Hsu et al.
PLOS ONE (2014)
Inflamed moods: A review of the interactions between inflammation and mood disorders
Joshua D. Rosenblat et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Proinflammation: the key to arterial aging
Mingyi Wang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects A Systematic Review and Meta-analysis of Randomized Clinical Trials
Ole Kohler et al.
JAMA PSYCHIATRY (2014)
Physical health of patients with bipolar disorder
A. H. Young et al.
ACTA PSYCHIATRICA SCANDINAVICA (2013)
Obesity and Bipolar Disorder: Synergistic Neurotoxic Effects?
Celina S. Liu et al.
ADVANCES IN THERAPY (2013)
Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
Davy Vancampfort et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Is bipolar disorder an inflammatory condition? The relevance of microglial activation
Laura Stertz et al.
CURRENT OPINION IN PSYCHIATRY (2013)
CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS
Andrew H. Miller et al.
DEPRESSION AND ANXIETY (2013)
Chemokines in bipolar disorder: Trait or state?
Izabela Guimaraes Barbosa et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
INFLAMMATORY CYTOKINES IN DEPRESSION: NEUROBIOLOGICAL MECHANISMS AND THERAPEUTIC IMPLICATIONS
J. C. Felger et al.
NEUROSCIENCE (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Neuroinflammatory basis of metabolic syndrome
Sudarshana Purkayastha et al.
MOLECULAR METABOLISM (2013)
Novel therapeutic targets in depression: Minocycline as a candidate treatment
Joanna K. Soczynska et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder
Sara K. Olsson et al.
BIPOLAR DISORDERS (2012)
Refractoriness in Bipolar Disorder: Definitions and Evidence-Based Treatment
Konstantinos N. Fountoulakis
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
Robert K. McNamara et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Cardiovascular Disease and Bipolar Disorder: Risk and Clinical Implications
Holly A. Swartz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis
Marc Udina et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder
Lev Gertsik et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection
Maryam Alavi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Microglia in the developing brain: A potential target with lifetime effects
G. Jean Harry et al.
NEUROTOXICOLOGY (2012)
Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample
Manuel Gurpegui et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Obesity in Bipolar Disorder: An Overview
Susan L. McElroy et al.
CURRENT PSYCHIATRY REPORTS (2012)
Microglial activation - tuning and pruning adult neurogenesis
Christine T. Ekdahl
FRONTIERS IN PHARMACOLOGY (2012)
Metabolism and the Brain
Oksana Kaidanovich-Beilin et al.
SCIENTIST (2012)
Atypical Antipsychotic-Induced Weight Gain Insights into Mechanisms of Action
James L. Roerig et al.
CNS DRUGS (2011)
Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
Johan Soderlund et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
Joanna K. Soczynska et al.
NEUROMOLECULAR MEDICINE (2011)
Dose-Dependent Effects of Endotoxin on Neurobehavioral Functions in Humans
Jan-Sebastian Grigoleit et al.
PLOS ONE (2011)
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
Marc De Hert et al.
WORLD PSYCHIATRY (2011)
Autoimmune diseases, bipolar disorder, and non-affective psychosis
William W. Eaton et al.
BIPOLAR DISORDERS (2010)
Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction
Keigan M. Park et al.
CELLULAR SIGNALLING (2010)
Bipolar disorder and metabolic syndrome: An international perspective
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
J. S. Rao et al.
MOLECULAR PSYCHIATRY (2010)
Prevalence of Mood and Anxiety Disorders in Women With Systemic Lupus Erythematosus
Elizabeth A. Bachen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity
Neil A. Harrison et al.
BIOLOGICAL PSYCHIATRY (2009)
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity
Daniel Lindqvist et al.
BIOLOGICAL PSYCHIATRY (2009)
Can body mass index help predict outcome in patients with bipolar disorder?
Cynthia Calkin et al.
BIPOLAR DISORDERS (2009)
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Elisa Brietzke et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Reduced mania and depression in juvenile bipolar disorder associated with long-chain ω-3 polyunsaturated fatty acid supplementation
E. H. Clayton et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2009)
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Elisa Brietzke et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature
Benjamin I. Goldstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder
Shima Jazayeri et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2008)
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
Fabiano G. Nery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway
R. R. Girgis et al.
MOLECULAR PSYCHIATRY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
The relationship between the fatty acid composition of immune cells and their function
Philip C. Calder
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Ethyl-eicosapentaenoic acid in first-episode psychosis: A randomized, placebo-controlled trial
Gregor E. Berger et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Yong-Ku Kim et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Christoph U. Correll et al.
SCHIZOPHRENIA RESEARCH (2007)
The metabolic syndrome, depression, and cardiovascular disease: Interrelated conditions that share pathophysiologic mechanisms
Rijk O. B. Gans
MEDICAL CLINICS OF NORTH AMERICA (2006)
Mood disorders: cardiovascular and diabetes comorbidity
Wayne S. Fenton et al.
CURRENT OPINION IN PSYCHIATRY (2006)
Acute inflammation and negative mood: Mediation by cytokine activation
CE Wright et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
Cytokines as mediators of depression: What can we learn from animal studies?
AJ Dunn et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C
CL Raison et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
Cardiovascular risk factors in outpatients with bipolar disorder
UMH Klumpers et al.
PHARMACOPSYCHIATRY (2004)
A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic
LJ Edwards et al.
MULTIPLE SCLEROSIS (2004)
Immunologic variables in acute mania of bipolar disorder
HC Liu et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment
L Capuron et al.
BIOLOGICAL PSYCHIATRY (2003)
Associations between cardiorespiratory fitness and C-reactive protein in men
TS Church et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
A dose-ranging study of the, effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
M Peet et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Mortality of patients with mood disorders: follow-up over 34-38 years
F Angst et al.
JOURNAL OF AFFECTIVE DISORDERS (2002)
High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure
RW Kupka et al.
BIOLOGICAL PSYCHIATRY (2002)
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
L Capuron et al.
MOLECULAR PSYCHIATRY (2002)
Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex
YB Bezchlibnyk et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy
L Capuron et al.
PSYCHONEUROENDOCRINOLOGY (2001)
Excess mortality in bipolar and unipolar disorder in Sweden
U Ösby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Cytokine-associated emotional and cognitive disturbances in humans
A Reichenberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)